dehydrocrenatidine and Nasopharyngeal-Neoplasms

dehydrocrenatidine has been researched along with Nasopharyngeal-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for dehydrocrenatidine and Nasopharyngeal-Neoplasms

Article	Year
Dehydrocrenatidine extracted from Oncology reports, 2021, Volume: 46, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Carbolines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phosphorylation; Picrasma; Plant Extracts	2021

Article

Year

Oncology reports, 2021, Volume: 46, Issue:2

Topics: Antineoplastic Agents, Phytogenic; Carbolines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phosphorylation; Picrasma; Plant Extracts

2021